Binding of rationally designed non-natural peptides to the human leukocyte antigen HLA-B*2705

Journal of Peptide Science

Volumn 4, Issue 6, 1998, Pages 378-388

  Krebs, Stefan ^a   Folkers, Gerd ^a   Rognan, Didier ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Circular dichroism; Computer aided ligand design; HLA B27; Thermal denaturation

Indexed keywords

HLA B27 ANTIGEN; PEPTIDE; PRIMER DNA; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CHEMICAL STRUCTURE; CIRCULAR DICHROISM; GEL CHROMATOGRAPHY; GENETICS; HUMAN; METABOLISM; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; SITE DIRECTED MUTAGENESIS; SYNTHESIS;

AMINO ACID SEQUENCE; BASE SEQUENCE; CHROMATOGRAPHY, GEL; CIRCULAR DICHROISM; DNA PRIMERS; HLA-B27 ANTIGEN; HUMANS; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; PEPTIDES; PROTEIN BINDING; RECOMBINANT PROTEINS;

EID: 0032150303     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1387(199809)4:6<378::AID-PSC157>3.0.CO;2-B     Document Type: Article

References (41)

1. M.T. Heemels and H.L. Ploegh (1995). Generation, translocation and presentation of MHC class I-restricted peptides. Ann. Rev. Biochem. 64, 643-691.
2. F. Garcia, A. Marina and J.A. López de Castro (1997). Lack of carboxy-terminal tyrosines distinguishes the B*2706-bound peptide repertoire from those of B*2704 and other HLA-B27 subtypes associated to ankylosing spondylitis. Tissue Antigens 49, 215-221.
3. M.T. Fiorillo, L. Meadows, M. D'Amato, J. Shabanowitz, D.F. Hunt, E. Apella and R. Sorrentino (1997). Susceptibility to ankylosing spondylitis correlates with the C-terminal residue of peptides presented by various HLA-B27 subtypes. Eur. J. Immunol. 27, 368-373.
4. R. Benjamin and P. Parham (1990). Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol. Today 11, 137-142.
5. L. Adorini, S. Muller, F. Cardinaux, P.V. Lehmann, F. Falcioni and Z.A. Nagy. (1988). In vivo competition between self peptides. Nature 334, 623-625.
6. M.T. De Magistris, J. Alexander, M. Coggeshall, A. Altman, F.C.A Gaeta., H.M. Grey and A. Sette (1992). Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell 68, 625-634.
7. G.Y. Ishioka, L. Adorini, J.C. Guery, F.C.A. Gaeta, R. LaFond, J. Alexander, M.F. Powell, A. Sette and H.M. Grey (1994). J. Immunol. 152, 4311-4319.
8. H.G. Rammensee (1995). Chemistry of peptides associated with MHC class I molecules. Curr. Opin. Immunol. 7, 85-96.
9. H.J. Fehling, W. Swat, C. Laplace, R. Kuhn, K. Rajewsky, U. Muller and H. von Boehmer (1994). MHC class I expression in mice lacking the proteasome subunit LMP-7. Science 265, 1234-1237.
10. T. Spies, M. Bresnahan, S. Bahram, D. Arnold, G. Blank, E. Mellins, D. Pious and R. DeMars (1990). A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway. Nature 348, 744-748.
11. A. Townsend, C. Ohlen, J. Bastin, H.G. Ljunggren, L. Foster and K. Karre (1989). Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 340, 443-448.
12. D.R. Madden, J.C. Gorga, J.L. Strominger and D.C. Wiley (1992). The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC. Cell 70, 1035-1048.
13. M. Bouvier and D.C. Wiley (1994). Importance of peptide amino and carboxyl termini to the stability of MHC class I molecules. Science 265, 398-402.
14. M.A. Saper, P.J. Bjorkman and D.C. Wiley (1991). Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution. J. Mol. Biol. 219, 277-319.
15. K. Falk, O. Rotzschke, S. Stevanovic, G. Jung and H.G. Rammensee (1991). Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351, 290-296.
16. D.N. Garboczi, P. Ghosh, U. Utz, Q.R. Fan, W.E. Biddison and D.C. Wiley (1996). Structure of the complex between human T- cell receptor, viral peptide and HLA-A2. Nature 384, 134-141.
17. J. Ruppert, J. Sidney, E. Celis, R.T. Kubo, H.M. Grey and A. Sette (1993). Prominent role of secondary anchor residues in peptide binding to HLA- A2.1 molecules. Cell 74, 929-937.
18. B. Galocha, J.R. Lamas, J.A. Villadangos, J.P. Albar and J.A. Lopez de Castro (1996). Binding of peptides naturally presented by HLA-B27 to the differentially disease-associated B*2704 and B*2706 subtypes, and to mutants mimicking their polymorphism. Tissue Antigens 48, 509-518.
19. D. Rognan, L. Scapozza, G. Folkers and A. Daser (1995). Rational design of nonnatural peptides as high-affinity ligands for the HLA-B*2705 human leucocyte antigen. Proc. Natl. Acad. Sci. 92, 753-757.
20. P. Rovero, S. Vigano and S. Pegorado (1995). Augmentation of the affinity of HLA class I-binding peptides lacking primary anchor residues by manipulation of the secondary anchor residues. J. Peptide Sci. 1, 266-273.
21. T.S. Jardetzky, W.S. Lane, R.A. Robinson, D.R. Madden and D.C. Wiley (1991). Identification of self-peptides bound to purified HLA-B27. Nature 353, 326-329.
22. O. Rotzschke, K. Falk, S. Stevanovic, V. Gnau, G. Jung and H.G. Rammensee (1994). Dominant aromatic/ aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs. Immunogenetics 39, 74-77.
23. K. Nagai and H.C. Thogersen (1987). Synthesis and sequence-specific proteolysis of hybrid proteins produced in Escherichia coli. Methods Enzymol. 153, 461-481.
24. J.W. Taylor, J. Ott and F. Eckstein (1985). The rapid generation of oligonucleotide-directed mutations at high frequency using phosphorothioatemodified DNA. Nucl. Acids Res. 13, 8764-8785.
25. P.L. Privalov and S.J. Gill (1988). Stability of protein structure and hydrophobic interaction. Adv. Prot. Chem. 39, 191-234.
26. J.K. Myers, C.N. Pace, J.M. Scholtz (1995). Denaturant m values and heat capacity changes: Relation to changes in accessible surface areas of protein unfolding. Protein Sci. 4, 2138-2148.
27. W.J. Becktel and J.A. Schellman (1987). Protein stability curves. Biopolymers 26, 549-559.
28. R.B. Young, M. Orcutt and P.B. Blauwiekel (1980). Quantitative measurement of protein mass and radioactivity in N,N′-diallyltartardiamide crosslinked polyacrylamide slab gels. Anal. Biochem. 108, 202-206.
29. M.L. Fahnestock, I. Tamir, L. Narhi and P.J. Bjorkman (1992). Thermal stability comparison of purified empty and peptide-filled forms of a MHC class I molecule. Science 258, 1658-1662.
30. C.S. Morgan, J.M. Holton, B.D. Olafson, P.J. Bjorkman and S.L. Mayo (1997). Circular dichroism determination of class I MHC-peptide equilibrium dissociation constants. Protein Sci. 6, 1771-1773.
31. D.M. Garboczi, D.T. Hung and D.C. Wiley (1992). HLA-A2-peptide complexes: refolding and crystallisation of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc. Natl. Acad. Sci. USA 89, 3429-3433.
32. Z. Reich, J.D. Altman, J.J. Boniface, D.S. Lyons, H. Kozono, G. Ogg, C. Morgan and M.M. Davis (1997). Stability of empty and peptide-loaded class II major histocomapibility complex molecules at neutral and endosomal pH: Comparison to class I proteins. Proc. Natl. Acad. Sci. 94, 2495-2500.
33. A. Daser, U. Henning and P. Henklein (1994). HLA-B27 binding peptides derived from the 57 kDa heat schock protein of Chlamydia trachomatis: novel insights into the peptide binding rules. Mol. Immunol. 31, 331-336.
34. P.J. Goodford (1985). A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J. Med. Chem. 28, 849-857.
35. G.A. Weiss, R.J. Valentekovich, E.J. Collins, D.N. Garboczi, W.S. Lane, S.L. Schreiber and D.C. Wiley (1996). Covalent HLA-B27/peptide complex induced by specific recognition of an aziridine mimic of arginine. Proc. Natl. Acad. Sci. 93, 10945-10948.
36. C.N. Pace (1986). Determination and analysis of urea and guanidinium hydrochloride denaturation curves. Methods Enzymol. 131, 266-280.
37. G. Guichard, S. Calbo, S. Muller, P. Kourilsky, J.P. Briand and J.P. Abastado (1995). Efficient binding of reduced peptide bond pseudopeptides to major histocompatibility complex class I molecule. J. Biol. Chem. 270, 26057-26059.
38. G. Guichard, F. Connan, R. Graff, M. Ostankovitch, S. Muller, J.G. Guillet, F. Choppin and J.P. Briand (1996). Partially modified retro-inverso pseudopeptides as non-natural ligands for the class I histocompatibility molecule HLA-A2. J. Med. Chem. 39, 2030-2039.
39. D. Rognan, S. Krebs, O. Kuonen, J.R. Lamas, J.A. Lopez de Castro and G. Folkers (1997). Fine specificity of antigen binding to two class I major histocompatibility proteins (B*2705 and B*2703) differing in a single amino acid residue. J. Comp. Aided Mol. Des. 11, 463-478.
40. G.A. Weiss, E.J. Collins, D.N. Garboczi, D.C. Wiley and S.L. Schreiber (1995). A tricyclic ring system replaces the variable regions of peptides presented by three alleles of human MHC class I molecules. Chem. Biol. 2, 401-407.
41. M. Bouvier and D.C. Wiley (1996). Antigenic peptides containing large PEG loops designed to extend out of the HLA-A2 binding site form stable complexes with class I major histocompatibility complex molecules. Proc. Natl. Acad. Sci. USA 93, 4583-4588.